About 100 Mg Dasatinib Tablets
Discover a top choice in oncology care with our 100 mg Dasatinib Tablets-now available as a hot deal for a limited time! Marked down for an astounding value, each HDPE bottle or blister pack contains 60 ravishing white to off-white film-coated tablets, meeting grandiose expectations in cancer therapy. Indicated for CML and ALL, this targeted prescription-only treatment boasts a shelf life of up to 36 months and is odorless. Dasatinib delivers powerful performance as an antineoplastic agent. Marketed, supplied, and exported from India, strictly on oncologist or hematologist prescription.
Exceptional Features & Application Advantages
100 mg Dasatinib Tablets are meticulously formulated for oral administration, guaranteeing ease of use and optimized absorption. Its competitive advantage lies in precise targeting of cancer cells with reduced impact on healthy tissue. As a film-coated, odorless tablet, it enhances patient compliance. Site of application is systemic, reaching intended target sites efficiently. Suitable storage below 30C with robust packaging ensures prolonged shelf life and safety, distinguishing this anticancer medication from competitors.
Domestic Market Presence & Global Supply Capacity
Dasatinib 100 mg tablets are in high demand across the main domestic market and are distributed via reliable trading channels. Packaging options include secure HDPE bottles or blister packs with prompt arrivals to major domestic and export destinations. With a steady supply ability and shipping flexibility via major FOB ports, distributors and suppliers can confidently meet ongoing oncology market needs while ensuring product integrity throughout the journey.
FAQ's of 100 Mg Dasatinib Tablets:
Q: How should 100 mg Dasatinib Tablets be stored to maintain their efficacy?
A: To ensure maximum effectiveness, store Dasatinib tablets below 30C, away from moisture, in their original HDPE bottles or blister packaging.
Q: What are the primary indications for using Dasatinib 100 mg tablets?
A: Dasatinib 100 mg is primarily indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) as a targeted antineoplastic agent.
Q: When should patients avoid using Dasatinib tablets?
A: These tablets should not be used by individuals with a known hypersensitivity to Dasatinib or any tablet excipients, and are not recommended during pregnancy (Pregnancy Category D).
Q: Where can Dasatinib 100 mg tablets be obtained?
A: The tablets are available through licensed pharmacies and distributors, but only with a valid prescription from an oncologist or hematologist.
Q: What benefits does the film-coated design of Dasatinib tablets offer?
A: The white to off-white, film-coated design helps improve patient compliance by making the tablets easier to swallow and masking any unpleasant taste.
Q: How does this anti-cancer medication achieve targeted treatment?
A: Dasatinib acts as a tyrosine kinase inhibitor, efficiently targeting cancerous cells and limiting effects on healthy tissues, making it a competitive choice for oncology therapy.